Status:
COMPLETED
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
Lead Sponsor:
University of Toledo Health Science Campus
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single bl...
Eligibility Criteria
Inclusion
- CHF
- 21 - 80 years
- Serum creatinine \< 2 mg/dL
- Serum potassium 2.7 - 4.5 mg/dL measured within past 4 weeks
Exclusion
- Less than 21 years
- Pregnancy
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00860340
Start Date
February 1 2003
End Date
October 1 2006
Last Update
December 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Ohio
Toledo, Ohio, United States, 43614